And I hope that over the years we will continue to see this momentum because people like what you've done, deserve this extraordinary recognition
Selecting the most appropriate GLP-1 receptor agonist requires consideration of multiple patient-specific factors, clinical characteristics, and treatment goals
In a 48-week clinical trial, higher doses consistently led to greater average weight loss: Weight loss by dose (48-week clinical trial) In this trial, at the highest dose (12 mg), people lost an average 24% of their starting weight on average
If your medication isnt on the list, youll need to request a "formulary exception" rather than filing a standard appeal
Talk to your healthcare provider about the steps youve taken, such as changes to your diet, weight loss surgery, exercise habits, or behavior, and be honest about what hasnt worked
Ligumsky (88) also discovered through animal experiments that GLP-1RA could suppress the proliferation of mouse breast cancer cells by triggering the expression of cAMP and CREB
